Pointe Scientific Cocaine Metabolite Enzyme Immunoassay
Enzyme Immunoassay, Cocaine And Cocaine Metabolites. 510(k) K191638, from Medtest DX (Lincoln Park, MI). Product code DIO, class 2.
As of Nov 18, 2026, K191638 is an FDA 510(k) held by Medtest DX, substantially equivalent on Mar 12, 2020 after 267 days, with no recalls tied to it in FDA's recall database.
- Review time: 267 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Pointe Scientific Cocaine Metabolite Enzyme Immunoassay is intended for the qualitative determination of benzoylecgonine (a cocaine metabolite) in human urine at a cutoff value of 150 ng/mL. Rx only. This assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Lzi Cocaine Metabolite Homogeneous Enzyme Immunoassay,Calibrators,ControlsK113139 · Lin-Zhi International, Inc. · Nov 22, 2011
Other DIO clearances
The newest 510(k)s for the same product code; see every DIO device- Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test SystemK213211 · Carolina Liquid Chemistries Corp. · Jan 27, 2022
- DRI Cocaine Metabolite AssayK211973 · Microgenics Corporation · Sep 24, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 19, 2019
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files